Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Why AbbVie Stock Slumped Today

The company, one of the rare healthcare sector Dividend Kings, wasn't looking too royal on the last trading day of the week.

Why AbbVie Stock Slumped Today

Published July 31, 2026 · Category: Finance

Overview

High-flying pharmaceutical company AbbVie (NYSE: ABBV) has seen its stock rise in many recent sessions. Yet Friday's wasn't one of them, as the company's shares took a nearly 3% loss on the back of a second-quarter earnings report that investors found uninspiring.

AbbVie unveiled that quarter's figures before market open. Its revenue came in at just under $17 billion for the period, which was more than 10% higher year over year. It also managed to boost its net income not under generally accepted accounting principles (non-GAAP, or adjusted) by 23% to almost $6.5 billion, or $3.65 per share.

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.